Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3789 Comparison of postoperative textbook outcome between pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma – A nationwide retrospective cohort study

Introduction: Pancreatic neuroendocrine tumors (pNET) represent only 6% of pancreatic tumors, compared to 93% for pancreatic ductal adenocarcinoma (PDAC). Textbook outcome (TO) is a composite outcome measure that reflects a hospital’s surgical performance as well as quality of current practice.

Conference:

Presenting Author: Chen J

Authors: Chen J, Augustinus S, Engelsman A, Bonsing B, Groot Koerkamp B,

Keywords: pNET, PDAC, Dutch Pancreatic Cancer Audit, Textbook Outcome, Postoperative results,

#3392 The chromosome 18 loss of heterozygosity axis of small intestinal neuroendocrine tumors

Introduction: Small intestinal neuroendocrine tumors (siNETs) are rare neoplasms which have low mutational burdens: With subtypes characterised in terms of copy number variation (CNV). Subtypes are defined as: Chromosome 18 loss of heterozygosity (18LOH), multiple copy number variation (MultiCNV), or no copy number variations (NoCNV). 18LOH tumors are associated with improved outcomes, the reasons for which are poorly understood.

Conference:

Presenting Author: Waterfield S

Authors: Waterfield S, Yousefi P, Amaulu A, Relton C, Thirlwell C,

Keywords: neuroendocrine, small intestinal, methylation, epigenetics, omics,

#2189 Perioperative Chemotherapy in Resectable Neuroendocrine Carcinomas of the Digestive Tract

Introduction: Neuroendocrine carcinomas (NEC), of the digestive tract are rare and aggressive tumours. In localised disease, the treatment is surgery, followed by administration of adjuvant chemotherapy combining etoposide and platinum salts, justified by the high risk of secondary metastasis. No clinical study has proven the benefit of chemotherapy, and recommendations are based on expert consensus.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Pellat A, Walter T, Hautefeuille V, Hentic O, Augustin J,

Keywords: neuroendocrine, carcinoma, chemotherapy, Ki-67,